Completed

TRISMUSEvaluation of the French Translation of Gothenburg Trismus Questionnaire (GTQ)

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Nervous System Diseases+4

+ Neurologic Manifestations

+ Signs and Symptoms

Over 18 Years
+2 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: December 2020
See protocol details

Summary

Principal SponsorCentre Hospitalier de Valence
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: December 22, 2020

Actual date on which the first participant was enrolled.

Trismus is defined as a limitation in the mouth/jaw-opening ability due to a reduced mandible mobility. Trismus can occur from benign jaw related conditions, often referred to as temporomandibular disorders (TMD). It can also result from local or metastatic tumor growth of head and neck (H\&N) tumors, and more importantly, as a debilitating side-effect to H\&N oncology treatment, especially radiotherapy The Gothenburg Trismus Questionnaire (GTQ) is a Patient Reported Outcome, validated in English, portuguese and sweden language. The aim of this study is to develop a new tool in french language and to evaluate the specific impact of trismus on quality of life .

Official TitleEvaluation of the French Translation of Gothenburg Trismus Questionnaire (GTQ)
NCT05615181
Principal SponsorCentre Hospitalier de Valence
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

310 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsSpasmPathological Conditions, Signs and SymptomsTrismusNeuromuscular Manifestations

Criteria

2 exclusion criteria prevent from participating
Patient under guardianship, deprived of liberty, safeguard of justice
Refusal to participate in research

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Ch Valence

Valence, FranceOpen Ch Valence in Google Maps
CompletedOne Study Center
TRISMUS | Evaluation of the French Translation of Gothenburg Trismus Questionnaire (GTQ) | PatLynk